Literature DB >> 24480727

Correlation between radiation dose and histopathological findings in patients with gliblastoma treated with boron neutron capture therapy (BNCT).

T Kageji1, Y Mizobuchi2, S Nagahiro2, Y Nakagawa3, H Kumada4.   

Abstract

The purpose of this study was to clarify the correlation between the radiation dose and histopathological findings in patients with glioblastoma multiforme (GBM) treated with boron neutron capture therapy (BNCT). Histopathological studies were performed on specimens from 8 patients, 3 had undergone salvage surgery and 5 were autopsied. For histopathological cure of GBM at the primary site, the optimal minimal dose to the gross tumor volume (GTV) and the clinical target volume (CTV) were 68Gy(w) and 44Gy(w), respectively.
Copyright © 2014. Published by Elsevier Ltd.

Entities:  

Keywords:  BNCT; Glioblatoma; Radiation

Mesh：

Substances：

Year:  2013        PMID： 24480727     DOI： 10.1016/j.apradiso.2013.12.014

Source DB:  PubMed          Journal:  Appl Radiat Isot        ISSN： 0969-8043            Impact factor:   1.513


  5 in total

Review 1.  Management of GBM: a problem of local recurrence.

Authors:  John P Kirkpatrick; Nadia N Laack; Helen A Shih; Vinai Gondi
Journal:  J Neurooncol       Date:  2017-04-04       Impact factor: 4.130

Review 2.  Boron Neutron Capture Therapy: A Review of Clinical Applications.

Authors:  Timothy D Malouff; Danushka S Seneviratne; Daniel K Ebner; William C Stross; Mark R Waddle; Daniel M Trifiletti; Sunil Krishnan
Journal:  Front Oncol       Date:  2021-02-26       Impact factor: 6.244

3.  Therapeutic nucleus-access BNCT drug combined CD47-targeting gene editing in glioblastoma.

Authors:  Jiejian Chen; Qi Dai; QiYao Yang; Xiaoyan Bao; Yi Zhou; Haiqing Zhong; Linjie Wu; Tiantian Wang; Zhicheng Zhang; Yiying Lu; Zhentao Zhang; Mengting Lin; Min Han; Qichun Wei
Journal:  J Nanobiotechnology       Date:  2022-03-04       Impact factor: 10.435

Review 4.  The use of radiosensitizing agents in the therapy of glioblastoma multiforme-a comprehensive review.

Authors:  Niklas Benedikt Pepper; Walter Stummer; Hans Theodor Eich
Journal:  Strahlenther Onkol       Date:  2022-05-03       Impact factor: 4.033

5.  Development of an integrated Monte Carlo model for glioblastoma multiforme treated with boron neutron capture therapy.

Authors:  Leyla Moghaddasi; Eva Bezak
Journal:  Sci Rep       Date:  2017-08-01       Impact factor: 4.379
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.